Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis.
Saved in:
| Title: | Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis. |
|---|---|
| Authors: | Vidula MK; Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Orlenko A; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Zhao L; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Salvador L; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Small AM; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA., Horton E; Department of Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Cohen JB; Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Adusumalli S; Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Denduluri S; Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Kobayashi T; Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Hyman M; Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Fiorilli P; Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Magro C; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Singh B; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Pourmussa B; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Greczylo C; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Basso M; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Ebert C; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Yarde M; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Li Z; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Cvijic ME; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Wang Z; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Walsh A; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Maranville J; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Kick E; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Luettgen J; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Adam L; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Schafer P; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Ramirez-Valle F; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Seiffert D; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Moore JH; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Gordon D; Bristol Myers Squibb Company, Lawrenceville, NJ, USA., Chirinos JA; Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. |
| Source: | European journal of heart failure [Eur J Heart Fail] 2021 Dec; Vol. 23 (12), pp. 2021-2032. Date of Electronic Publication: 2021 Oct 21. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
